Annual report
4882.TEDINET S100TOCF
Period2023-04-01 → 2024-03-31
Filed2024-06-20
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amended by S100W63I (2025-06-27).
Key figures · 77
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥100m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥94m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥72m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥68m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥86m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥895m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥698m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥879m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥690m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥482m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥410m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥834m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥785m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥787m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥599m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥413m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥842m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥548m | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥295m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥170m | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥486m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2022-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥482m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥834m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥564m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥477m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥423m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥609m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥150m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥213m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥34m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥64m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥20,000 | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-93.69 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.93 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.47 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-59.03 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-136.95 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥110.94 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥201.13 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥268.05 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥128.86 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥79.05 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 11,936,400 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,759,400 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,759,400 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,386,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,146,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 25 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 24 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 21 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 19 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 21 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 740
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYearDuration_NonConsolidatedMember | 63475000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | CurrentYearDuration_NonConsolidatedMember | 566000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration_NonConsolidatedMember | -20000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration_NonConsolidatedMember | -1000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration_NonConsolidatedMember | -20000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration_NonConsolidatedMember | 63943000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | 7365000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | 16783000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | -769918000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | -903514000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 3214852000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2444934000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 2444934000 | JPY |
| Cash and cash equivalents | CurrentYearInstant_NonConsolidatedMember | 1541419000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 36337000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 37759000 | JPY |
| Commission fee sga | Prior1YearDuration_NonConsolidatedMember | 77921000 | JPY |
| Commission fee sga | CurrentYearDuration_NonConsolidatedMember | 109456000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 494494000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 616004000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration_NonConsolidatedMember | 494494000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration_NonConsolidatedMember | 616004000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-06-20 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第24期（自 2023年４月１日 至 2024年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ペルセウスプロテオミクス | |
| Company name in english cover page | FilingDateInstant | Perseus Proteomics Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長執行役員 横川 拓哉 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋箱崎町30番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6264-8268（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役執行役員管理部長 鈴川 信一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋箱崎町30番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-6264-8268（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役執行役員管理部長 鈴川 信一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E35510 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 48820 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ペルセウスプロテオミクス | |
| Filer name in english | FilingDateInstant | Perseus Proteomics Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |